519 related articles for article (PubMed ID: 10405940)
1. Corticosteroid resistant interstitial pneumonitis in dermatomyositis/polymyositis: prediction and treatment with cyclosporine.
Nawata Y; Kurasawa K; Takabayashi K; Miike S; Watanabe N; Hiraguri M; Kita Y; Kawai M; Saito Y; Iwamoto I
J Rheumatol; 1999 Jul; 26(7):1527-33. PubMed ID: 10405940
[TBL] [Abstract][Full Text] [Related]
2. Differences in clinical features and prognosis of interstitial lung diseases between polymyositis and dermatomyositis.
Fujisawa T; Suda T; Nakamura Y; Enomoto N; Ide K; Toyoshima M; Uchiyama H; Tamura R; Ida M; Yagi T; Yasuda K; Genma H; Hayakawa H; Chida K; Nakamura H
J Rheumatol; 2005 Jan; 32(1):58-64. PubMed ID: 15630726
[TBL] [Abstract][Full Text] [Related]
3. [Prognosis of interstitial pneumonitis (IP) in polymyositis (PM)/dermatomyositis (DM)].
Saeki T; Suzuki E; Watanabe T; Saito Y; Itou S; Honma T; Sato T; Nakano M; Arakawa M
Ryumachi; 1994 Feb; 34(1):16-21. PubMed ID: 8146722
[TBL] [Abstract][Full Text] [Related]
4. [Nation-wide survey for the treatment with cyclosporin A of interstitial pneumonia associated with collagen diseases].
Harigai M; Hara M; Kamatani N; Kashiwazaki S
Ryumachi; 1999 Dec; 39(6):819-28. PubMed ID: 10695405
[TBL] [Abstract][Full Text] [Related]
5. Activation of pulmonary T cells in corticosteroid-resistant and -sensitive interstitial pneumonitis in dermatomyositis/polymyositis.
Kurasawa K; Nawata Y; Takabayashi K; Kumano K; Kita Y; Takiguchi Y; Kuriyama T; Sueishi M; Saito Y; Iwamoto I
Clin Exp Immunol; 2002 Sep; 129(3):541-8. PubMed ID: 12197897
[TBL] [Abstract][Full Text] [Related]
6. Combination therapy with corticosteroids, cyclosporin A, and intravenous pulse cyclophosphamide for acute/subacute interstitial pneumonia in patients with dermatomyositis.
Kameda H; Nagasawa H; Ogawa H; Sekiguchi N; Takei H; Tokuhira M; Amano K; Takeuchi T
J Rheumatol; 2005 Sep; 32(9):1719-26. PubMed ID: 16142867
[TBL] [Abstract][Full Text] [Related]
7. Role of endothelial damage in the pathogenesis of interstitial pneumonitis in patients with polymyositis and dermatomyositis.
Funauchi M; Shimadsu H; Tamaki C; Yamagata T; Nozaki Y; Sugiyama M; Ikoma S; Kinoshita K
J Rheumatol; 2006 May; 33(5):903-6. PubMed ID: 16652421
[TBL] [Abstract][Full Text] [Related]
8. Pneumomediastinum in interstitial lung disease associated with dermatomyositis and polymyositis.
Le Goff B; Chérin P; Cantagrel A; Gayraud M; Hachulla E; Laborde F; Papo T; Sibilia J; Zabraniecki L; Ravaud P; Puéchal X
Arthritis Rheum; 2009 Jan; 61(1):108-18. PubMed ID: 19116970
[TBL] [Abstract][Full Text] [Related]
9. [Clinical analysis of pneumomediastinum complicated in polymyositis and dermatomyositis].
Tong SQ; Shi XH; Su JM; Zhao Y; Zhang FC
Zhonghua Yi Xue Za Zhi; 2006 Mar; 86(9):624-7. PubMed ID: 16681909
[TBL] [Abstract][Full Text] [Related]
10. [Relationship between the onset and outcome of interstitial pneumonia associated with polymyositis and dermatomyositis].
Saku N; Ohno S; Sugiyama Y; Kitamura S
Nihon Kokyuki Gakkai Zasshi; 1998 Jul; 36(7):585-9. PubMed ID: 9805908
[TBL] [Abstract][Full Text] [Related]
11. Predictive factors and unfavourable prognostic factors of interstitial lung disease in patients with polymyositis or dermatomyositis: a retrospective study.
Ji SY; Zeng FQ; Guo Q; Tan GZ; Tang HF; Luo YJ; Tang ZQ; Han YF
Chin Med J (Engl); 2010 Mar; 123(5):517-22. PubMed ID: 20367973
[TBL] [Abstract][Full Text] [Related]
12. Elevation of cytokeratin 19 fragment in patients with interstitial pneumonia associated with polymyositis/dermatomyositis.
Fujita J; Dobashi N; Tokuda M; Bandoh S; Ohtsuki Y; Yamadori I; Yoshinouchi T; Ueda Y; Takahara J
J Rheumatol; 1999 Nov; 26(11):2377-82. PubMed ID: 10555895
[TBL] [Abstract][Full Text] [Related]
13. Early intervention with corticosteroids and cyclosporin A and 2-hour postdose blood concentration monitoring improves the prognosis of acute/subacute interstitial pneumonia in dermatomyositis.
Kotani T; Makino S; Takeuchi T; Kagitani M; Shoda T; Hata A; Tabushi Y; Hanafusa T
J Rheumatol; 2008 Feb; 35(2):254-9. PubMed ID: 18085732
[TBL] [Abstract][Full Text] [Related]
14. Transbronchial biopsy is clinically useful in classifying patients with interstitial pneumonia associated with polymyositis and dermatomyositis.
Mochimaru H; Kawamoto M; Enomoto T; Saitoh Y; Abe S; Nei T; Fukuda Y; Kudoh S
Respirology; 2008 Nov; 13(6):863-70. PubMed ID: 18811885
[TBL] [Abstract][Full Text] [Related]
15. Cyclosporine treatment for polymyositis/dermatomyositis: is it possible to rescue the deteriorating cases with interstitial pneumonitis?
Maeda K; Kimura R; Komuta K; Igarashi T
Scand J Rheumatol; 1997; 26(1):24-9. PubMed ID: 9057798
[TBL] [Abstract][Full Text] [Related]
16. Opportunistic infections in polymyositis and dermatomyositis.
Marie I; Hachulla E; Chérin P; Hellot MF; Herson S; Levesque H; Hatron PY
Arthritis Rheum; 2005 Apr; 53(2):155-65. PubMed ID: 15818648
[TBL] [Abstract][Full Text] [Related]
17. [The predictive factors and unfavourable prognostic factors of interstitial lung disease in patients with polymyositis/dermatomyositis].
Wang PZ; Guan JL; Han XH
Zhonghua Jie He He Hu Xi Za Zhi; 2008 Jun; 31(6):417-20. PubMed ID: 19031800
[TBL] [Abstract][Full Text] [Related]
18. Usefulness of cyclosporine A on rapidly progressive interstitial pneumonia in dermatomyositis.
Miyake S; Ohtani Y; Sawada M; Inase N; Miyazaki Y; Takano S; Miyasaka N; Yoshizawa Y
Sarcoidosis Vasc Diffuse Lung Dis; 2002 Jun; 19(2):128-33. PubMed ID: 12102608
[TBL] [Abstract][Full Text] [Related]
19. Effect of early treatment in polymyositis and dermatomyositis.
Naji P; Shahram F; Nadji A; Davatchi F
Neurol India; 2010; 58(1):58-61. PubMed ID: 20228465
[TBL] [Abstract][Full Text] [Related]
20. Polymyositis/dermatomyositis and interstitial lung disease: a new therapeutic approach with T-cell-specific immunosuppressants.
Takada K; Nagasaka K; Miyasaka N
Autoimmunity; 2005 Aug; 38(5):383-92. PubMed ID: 16227154
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
